Skip to contentApplication 761210
- Type
- BLA
- Sponsor
- JANSSEN BIOTECH
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | RYBREVANT | AMIVANTAMAB-VMJW | INJECTABLE;INJECTION | 350MG/7ML(50MG/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 57894-501 | Rybrevant | Amivantamab | Janssen Biotech, Inc. | BLA | Current |
| 57894-501 | Rybrevant | Amivantamab | Janssen Biotech, Inc. | BLA | Current |
| 57894-501 | Rybrevant | Amivantamab | Janssen Biotech, Inc. | BLA | Current |
| 57894-501 | Rybrevant | Amivantamab | Janssen Biotech, Inc. | BLA | Current |
| 57894-501 | Rybrevant | Amivantamab | Janssen Biotech, Inc. | BLA | Current |